Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

3.0K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
3.0K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

285
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
285
Male Sexual Response: Erection & Ejaculation01:17

Male Sexual Response: Erection & Ejaculation

7.8K
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
7.8K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

38
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
38
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

113
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
113
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

77
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
77

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal study of changes in walking and cognition by motor subtype of Parkinson's disease.

Parkinsonism & related disorders·2026
Same author

Walking Modulates Active Auditory Sensing.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2025
Same author

Beyond-local neural information processing in neuronal networks.

Computational and structural biotechnology journal·2024
Same author

Clustering Patterns of 24-Hour Physical Activity in Children 6-36 Months Old.

Pediatric exercise science·2024
Same author

Long-term outcomes and cost savings of office fulguration of papillary Ta low-grade bladder cancer.

BJU international·2023
Same author

Poly(adenosine diphosphate-ribose) polymerase inhibitor combinations in first-line metastatic castrate-resistant prostate cancer setting: a systematic review and meta-analysis.

BJU international·2023

Related Experiment Video

Updated: Oct 25, 2025

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

369

Complete study for erectile dysfunction (CompED) improving diagnosis and treatment decision-making.

Julian Chavarriaga1,2, Juan Prada1, Peter Olejua3

  • 1Division of Urology, Hospital Universitario San Ignacio. Pontificia Universidad Javeriana, Bogotá, Colombia.

Andrologia
|August 10, 2021
PubMed
Summary

The CompED test aids in evaluating erectile dysfunction (ED) by integrating rigidity testing, biothesiometry, and Doppler ultrasound. This comprehensive approach simplifies treatment decisions and improves patient selection for ED studies.

Keywords:
doppler Ultrasounddysfunctionerectileinhibitorsphosphodiesterase 5vasculogenic impotence

More Related Videos

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents
08:03

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents

Published on: June 6, 2018

14.5K
Author Spotlight: Advanced Treatment of Seminal Duct Blockage Employing Endoscopy-Mediated Semen Channel Refluviation
03:51

Author Spotlight: Advanced Treatment of Seminal Duct Blockage Employing Endoscopy-Mediated Semen Channel Refluviation

Published on: December 8, 2023

3.4K

Related Experiment Videos

Last Updated: Oct 25, 2025

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

369
Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents
08:03

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents

Published on: June 6, 2018

14.5K
Author Spotlight: Advanced Treatment of Seminal Duct Blockage Employing Endoscopy-Mediated Semen Channel Refluviation
03:51

Author Spotlight: Advanced Treatment of Seminal Duct Blockage Employing Endoscopy-Mediated Semen Channel Refluviation

Published on: December 8, 2023

3.4K

Area of Science:

  • Urology
  • Andrology
  • Men's Health

Background:

  • Erectile dysfunction (ED) is a common condition, often associated with aging.
  • Comprehensive patient evaluation and a stepwise management approach are crucial for ED.
  • Existing diagnostic methods for ED can be time-consuming and may not always pinpoint the etiology effectively.

Purpose of the Study:

  • To evaluate the utility of a comprehensive erectile dysfunction (CompED) test in clinical practice.
  • To determine if the CompED test facilitates treatment decision-making for patients with ED.
  • To identify clinical variables that predict abnormal CompED test results and optimize patient selection.

Main Methods:

  • Prospective data collection and analysis of 187 patients undergoing evaluation for ED.
  • The CompED test incorporated intracavernous injection rigidity testing, biothesiometry, and color duplex Doppler ultrasound.
  • Statistical analysis to identify predictors of abnormal test results and assess the impact on treatment decisions.

Main Results:

  • Abnormal results were observed in 31.2% (rigidity), 28.5% (peak systolic velocity), 13.2% (end-diastolic velocity), and 27.5% (biothesiometry).
  • Predictors of abnormal CompED test results included age over 70, low IIEF domain A scores (<14), and prior radical prostatectomy or radiotherapy.
  • The CompED test demonstrated potential in easing treatment decision-making for ED.

Conclusions:

  • The CompED test offers a novel, less time-consuming alternative for evaluating erectile dysfunction.
  • This integrated approach aids in more accurate etiological determination and guides treatment selection.
  • The CompED test can improve patient selection for further diagnostic studies in ED management.